Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transbucal Dexmedetomidine for Emergence Agitation in Children
NCT02720705Phase 3Completed
- Sponsor
- Assiut University
- Start
- May 2016
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine in Emergence agitation (EA) (3 arms), sponsored by Assiut University. Primary endpoint: Agitation Score. Started May 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on NCT02720705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02720705.